Usually one partner is known to carry a structural rearrangement which, if passed in an unbalanced form to their children, would result in a severe genetic disorder.
If PGT-SR is appropriate for a couple it is usually recommended by the Clinical Genetics service, and the couple is referred to a fertility clinic who will arrange the Feasibility Testing and the IVF treatment.
In most cases PGT-SR is funded, although there may be a waiting list to begin the process.
Genetics - Molecular Pathology
Please store biopsies in a -80 freezer if they arrive out of hours.
Patient sample: Trophectoderm biopsies from day 5-7 blastocysts
Samples should be collected into 2.5uL of 1x PBS already aliquoted in a 0.2mL PCR tube. Please contact the laboratory at firstname.lastname@example.org if you require tubes.
All testing is arranged through the fertility clinic directly with CHL.
PGT-SR involves analysis of embryos produced during in vitro fertilisation (IVF) to identify embryos that have abnormal chromosome copy numbers (aneuploidy). CHL uses ReproSeq™ by ThermoFisher Scientific to undertake PGT-SR.
$501.76 (Exclusive of GST)
"*" indicates required fields